Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Gains 7%; BSE HEALTHCARE Index Up 0.5%
Fri, 5 Jul 10:3

MARKSANS PHARMA. Gains 7%; BSE HEALTHCARE Index Up 0.5%Image source: phive2015/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 7% and is presently trading at Rs 175.4.

Meanwhile, the BSE HEALTHCARE index is at 38,055.6 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are Glenmark Pharma (up 2.5%) and FORTIS HEALTHCARE (up 2.3%).

ASTRAZENECA PHARMA (down 1.8%) and METROPOLIS HEALTHCARE (down 1.8%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 92.7 to Rs 175.4, registering a gain of Rs 82.7 (up 89.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 38,055.6, registering a gain of 48.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.3%), Cadila Healthcare (up 98.6%) and Lupin (up 97.8%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,532.1 (down 0.6%).

The top losers among the BSE Sensex today are HDFC Bank (down 4.1%) and M&M (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,187.4 (down 0.5%). HDFC Bank and M&M are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,532.1, registering a gain of 14,327.1 points (up 22.0%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit fell 6.1% YoY to Rs 776 million for the quarter ended March 2024, compared to a profit of Rs 827 million a year ago. Net sales rose 15.2% to Rs 5,600 million during the period as against Rs 4,860 million in January-March 2023.

For the year ended March 2023, MARKSANS PHARMA. reported 42.0% increase in net profit to Rs 2,653 million compared to net profit of Rs 1,868 million during FY22. Revenue of the company grew 24.2% to Rs 18,521 million during FY23.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 25.2.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 7%; BSE HEALTHCARE Index Up 0.5%". Click here!